On June 18th, 2021, the good news came! Icomoon Capital successfully registered as licensed private equity fund manager of Asset Management Association of China. Registration code: P1072074.

历时10个月，20余次线上线下讨论，横跨14个省市，汇集医疗机构、工程院校、器械企业、投资机构等53家单位参与，65位专家共同编撰。2021年11月18日，由中国心血管医生创新俱乐部CCI牵头撰写的中国心血管医疗器械领域首份产业创新白皮书--《中国心血管医疗器械产业创新白皮书（2021）》在国家放射与治疗临床医学研究中心2021年会上正式发布，皓越资本参与编写。

Icomoon capital's first equity investment fund: Nanjing Jiansu Equity Investment Partnership( AMAC code: SQW831) has completed its fund raising and registration in Asset management association China.

Tupai (Beijing) Medical Technology Co., LTD. (hereinafter referred to as "Tupai Medical"), a leading company in the independent research and development of ophthalmic equipment in China, has recent...

On December 23, 2023, in order to thank investors for their support and love, Jiangsu Haoyue Private Equity Fund Management Co., Ltd. successfully held the first closed-door meeting since its estab...

Warren Buffett once said, "A vague right is far better than a precise wrong."In every major crisis, when Buffett bought, the prediction market mocked him for "buying too high" or "getting caught up...

In 2023, technological developments and political changes bend time and space. By 2030, this will be the prime time window for artificial intelligence!The application of artificial intelligence in ...

Recently, China's capital market has experienced an unprecedented shock, with the stock index rising rapidly from 2689.07 points to 3674.4 points in just 6 days, attracting national attention. It a...

Recently, we have held two consecutive investor meetings for different funds to report and share the latest developments of the funds with our investors. During the meetings, some investors raised ...